Drugs that contain Tramadol Hydrochloride
1. Conzip patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7858118 | CIPHER PHARMS INC | Extended release composition containing Tramadol |
Apr, 2022
(2 years ago) | |
Market Authorisation Date: 07 May, 2010
Treatment: Use of tramadol for the management of moderate to moderately severe chronic pain
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
CONZIP family patents
2. Qdolo patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11103452 | ATHENA | Tramadol hydrochloride solution |
Sep, 2040
(16 years from now) | |
| US11752103 | ATHENA | Tramadol hydrochloride solution |
Sep, 2040
(16 years from now) | |
Market Authorisation Date: 01 September, 2020
Treatment: Management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate
Dosage: SOLUTION;ORAL
QDOLO family patents
3. Rybix Odt patents
expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5464632 | SHIONOGI INC | Rapidly disintegratable multiparticular tablet |
Mar, 2013
(11 years ago) | |
| US6106861 | SHIONOGI INC | Multiparticulate tablet disintegrating in less than 40 seconds in the mouth |
Dec, 2017
(6 years ago) | |
Market Authorisation Date: 05 May, 2005
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
RYBIX ODT family patents
4. Ryzolt patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5591452 | PURDUE PHARMA | Controlled release formulation |
May, 2014
(10 years ago) | |
| US6254887 | PURDUE PHARMA | Controlled release tramadol |
May, 2014
(10 years ago) | |
| US6607748 | PURDUE PHARMA | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
Jun, 2020
(3 years ago) | |
| US7988998 | PURDUE PHARMA | Sustained-release tramadol formulations with 24-hour efficacy |
Oct, 2023
(6 months ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Dec 30, 2011 |
Market Authorisation Date: 30 December, 2008
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
RYZOLT family patents
5. Ultram patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6339105 | JANSSEN PHARMS | Analgesic regimen |
Oct, 2019
(4 years ago) | |
|
US6339105 (Pediatric) | JANSSEN PHARMS | Analgesic regimen |
Apr, 2020
(4 years ago) | |
Market Authorisation Date: 03 March, 1995
Treatment: A titration dosing regimen for the treatment of pain using an initial dose of about 25mg
Dosage: TABLET;ORAL
ULTRAM family patents